Rocket Lab Corp. (RKLB)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-04
$64.26+0.71%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-04
QuarterlyIQ Insights · RKLB
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -44.1% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 57.0% |
Growth built into the price is above our model estimate.
The price assumes 101.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 55 industry peers · Company calendar date is not available
RKLB — debt issuance
Dated 2026-05-08
Other Events. On May 8, 2026, Rocket Lab Corporation (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on March 11, 2025 (File No. 333-285707), as amended by the Post-Effective Amendment No. 1 filed with the SEC on May 27, 2025 (the “Registration Statement”), covering the resale by certain selling stockholders of up to 2,277,002 shares of the…
Why it matters: This margin range shows how well costs are managed. Meeting it means Rocket Lab controls costs.
Supportive ifGAAP gross margin reported in Q2 2026 is between 33% and 35%.
Worry ifGAAP gross margin falls below 33%, showing cost control issues.
Why it matters: Good integration can boost Rocket Lab's skills and market position. It is key for growth.
Supportive ifManagement will share news about how the Mynaric acquisition is going. They will talk about any benefits from this acquisition.
Worry ifThere are reports of integration problems or delays.
Why it matters: Sales from this program will help fund the Iridium acquisition and future growth.
Watch forRocket Lab reports successful share sales under the ATM program. This raises a lot of money.
Also watch forNo sales happen under the ATM program. This shows possible market resistance or delays.
Why it matters: This merger could enhance Rocket Lab's capabilities and market position. It is a key strategic move.
Supportive ifAn official announcement says the merger is done. It also explains the benefits.
Worry ifMerger talks slow down or have regulatory problems.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$432 on $10,000 · ±4.3% | How much price usually moves either way. |
| Bad day | $994 loss on $10,000 · 9.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,099 loss on $10,000 · 61.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A smooth transition helps keep operations steady and financial reports clear. This is key for future plans.
Watch forThere are positive comments about the new CFO. They say he helps finances and operations.
Also watch forThere are worries that the transition may hurt financial reports. It could also affect plans.
Why it matters: This loss range shows if Rocket Lab controls expenses well. Meeting it means stable finances.
Worry ifAdjusted EBITDA loss reported in Q2 2026 is between $20M and $26M.
Less concerning ifAdjusted EBITDA loss is over $26M. This shows worse financial control.
Why it matters: Hitting or beating revenue goals shows strong demand and good operations. It shows Rocket Lab is growing.
Supportive ifQ3 2026 revenue reported at $250 million or higher.
Worry ifQ3 2026 revenue falls below $250 million.
Why it matters: A growing backlog indicates strong future revenue potential. It shows Rocket Lab's ability to secure contracts and expand its market share.
Supportive ifBacklog reported at $2.5 billion or more in Q3 2026.
Worry ifBacklog reported below $2.5 billion in Q3 2026.
Why it matters: Progress on the Neutron rocket is very important for Rocket Lab's future. Key milestones show they are ready for the market.
Supportive ifImportant milestones reached, like first flight hardware ready by Q4 2026.
Worry ifDelays in Neutron development or missed milestones push the first flight beyond Q4 2026.
Why it matters: Finishing the Iridium deal is important for Rocket Lab's growth. It will improve their satellite communication skills and create new ways to make money.
Supportive ifThe deal will close by mid-2027 if all approvals are granted.
Worry ifThe acquisition fails to close or faces significant delays beyond mid-2027.